Department of Ultrasound, Second Affiliated Hospital of Zhejiang University, Hangzhou, China.
In-patient Ultrasound Department, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Ultraschall Med. 2022 Feb;43(1):64-71. doi: 10.1055/a-1168-6321. Epub 2020 Jul 8.
To determine the diagnostic performance and inter-reader agreement of the contrast-enhanced ultrasound liver imaging reporting and data system (CEUS-LI-RADS) for diagnosing hepatocellular carcinoma (HCC) in high-risk patients.
In this prospective study, CEUS-LI-RADS categories (LR-5 for predicting HCC) were assigned by six blinded readers and compared to the definitive HCC diagnosis in patients with liver cirrhosis per the 2017 China Liver Cancer Guidelines (CLCG). CEUS features were recorded in 96 patients with 96 histology-proven lesions. The diagnostic performance of LR-5 was described by the sensitivity, specificity and accuracy. Multi-reader agreement was assessed by using intraclass correlation coefficients (ICC).
In cirrhotic patients, the specificity of LR-5 (range: 92.7-100.0 %) was statistically higher than that of CLCG for each reader (range: 28.6-64.3 %). However, the sensitivity (range: 38.6-63.6 %) and accuracy (range: 53.4-70.7 %) were statistically lower in CEUS-LIRADS than in CLCG (sensitivity range: 88.6-100.0 %; accuracy range: 77.6-86.2 %). Only fair to moderate inter-reader agreement was achieved for the CEUS-LI-RADS category (ICC = 0.595) and washout appearance (ICC range: 0.338 to 0.555). Neither nodule-in-nodule nor mosaic architecture was observed more often in HCC (all P > 0.05), with poor inter-reader consistency for both (both ICC < 0.20).
CEUS-LI-RADS category 5 has a high specificity but a low accuracy for identifying HCC in high-risk patients. Inter-reader agreement is not satisfactory concerning CEUS-LIRADS category and washout appearance. Moreover, the clinical value of ancillary features favoring HCC is quite limited.
评估增强超声肝脏影像报告与数据系统(CEUS-LI-RADS)在诊断高危人群肝细胞癌(HCC)中的诊断性能和观察者间一致性。
前瞻性研究中,由 6 位盲法观察者对 CEUS-LI-RADS 分类(LR-5 预测 HCC)进行评估,并根据 2017 年中国肝癌诊疗规范(CLCG)对肝硬化患者的明确 HCC 诊断进行比较。对 96 例经组织学证实的病变患者记录 CEUS 特征。通过敏感性、特异性和准确性描述 LR-5 的诊断性能。使用组内相关系数(ICC)评估多观察者间的一致性。
在肝硬化患者中,LR-5 的特异性(范围:92.7-100.0%)明显高于每位观察者的 CLCG(范围:28.6-64.3%)(P<0.05)。然而,CEUS-LIRADS 的敏感性(范围:38.6-63.6%)和准确性(范围:53.4-70.7%)明显低于 CLCG(敏感性范围:88.6-100.0%;准确性范围:77.6-86.2%)(P<0.05)。CEUS-LI-RADS 分类(ICC=0.595)和洗脱外观(ICC 范围:0.338 至 0.555)的观察者间一致性仅为中等至一般。两种情况下 HCC 结节内结节或马赛克结构均不常见(均 P>0.05),且观察者间一致性较差(均 ICC<0.20)。
CEUS-LI-RADS 分类 5 对识别高危人群中的 HCC 具有较高的特异性,但准确性较低。CEUS-LIRADS 分类和洗脱外观的观察者间一致性均不理想。此外,支持 HCC 的辅助特征的临床价值相当有限。